Commentary

Commentary

The Administration Risks Drug Shortages That Will Cost Patients Dearly

Judged by its actions, the Trump Administration supports drug shortages. Clearly, this is not the President’s stated goal, but it is the inevitable result of his policies including his proposed drug tariffs and most favored nation (MFN) policies. Read the op-ed here.
Commentary

Kennedy’s Vaccine Policies Put Americans at Risk in More Ways Than One

The effects of Kennedy’s vaccines policies are going to hurt Americans – and not just because more people are falling ill. Health experts, former CDC directors, and medical associations are gravely concerned that HHS Secretary RFK Jr.’s actions are risking Americans’ health and wellbeing. Nine former directors of the CDC ...
Commentary

Doctors and patients have endured enough pay cuts from Medicare

Doctors who treat Medicare beneficiaries are in for leaner times, judging from the program’s recently announced reimbursement update. And it will be those beneficiaries who will pay the price. The proposed changes to Medicare’s “fee schedule” would technically increase doctor reimbursement by 2.5%. But the government is also proposing to ...
Commentary

Cashing In On University Patents Means Giving Up On Our Innovation Future

Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation ...
Commentary

America Can’t Tariff Its Way to a Manufacturing Boom

President Trump very recently signed an executive order exempting a range of products from his proposed tariffs, including some pharmaceuticals. One day prior, he issued an order exempting generic pharmaceuticals from Japan from tariffs. It’s encouraging news, to be sure — particularly for American patients. But policies which shield vital ...
Commentary

The illicit trade in weight-loss drugs deserves a crackdown

The market for illicit weight-loss drugs is booming in plain sight. Law enforcement officials will have no choice but to act soon. In July, telehealth firm Hims & Hers was hit with a securities lawsuit alleging that the company sold unapproved knock-off compounded versions of Wegovy in violation of its ...
Commentary

Republicans Must Stand Their Ground On Enhanced Obamacare Subsidies

A group of Republican lawmakers is trying to preserve one of the worst mistakes of former President Biden’s tenure—the enhanced subsidies for health insurance sold through Obamacare’s exchanges. The subsidies—which were first enacted on an explicitly temporary basis during the pandemic before being renewed in 2022—are set to expire at ...
Business & Economics

Penalizing Mergers And Acquisitions Won’t Accelerate Economic Growth

The U.S. is mired in a growth slowdown… The growth slowdown is not preordained; it is a policy driven outcome that can be reversed by implementing the right reforms. Toward this goal, a ruling by the U.S. Tax Court this past summer made small but significant progress. Read the op-ed ...
Commentary

Business Policy CMS Shouldn’t Expand Its Broken Competitive Bidding Model

Durable medical equipment (DME) such as CPAP machines and hospital beds helps keep many patients out of expensive nursing home care and in their own homes. Unfortunately, creating the right payment model has long eluded the Centers for Medicare and Medicaid Services (CMS). Disconcertingly, they now plan to expand a ...
Commentary

Valley residents are growing alarmed by solar-and-battery project taking over farmland. Here’s why.

We’ve been assured for quite some time that wind and solar are the energy sources of the future. If so, their development needs to be accelerated because they are not being well received by locals. Their low energy density is partly, if not largely, to blame. Fresno County residents are ...
Commentary

The Administration Risks Drug Shortages That Will Cost Patients Dearly

Judged by its actions, the Trump Administration supports drug shortages. Clearly, this is not the President’s stated goal, but it is the inevitable result of his policies including his proposed drug tariffs and most favored nation (MFN) policies. Read the op-ed here.
Commentary

Kennedy’s Vaccine Policies Put Americans at Risk in More Ways Than One

The effects of Kennedy’s vaccines policies are going to hurt Americans – and not just because more people are falling ill. Health experts, former CDC directors, and medical associations are gravely concerned that HHS Secretary RFK Jr.’s actions are risking Americans’ health and wellbeing. Nine former directors of the CDC ...
Commentary

Doctors and patients have endured enough pay cuts from Medicare

Doctors who treat Medicare beneficiaries are in for leaner times, judging from the program’s recently announced reimbursement update. And it will be those beneficiaries who will pay the price. The proposed changes to Medicare’s “fee schedule” would technically increase doctor reimbursement by 2.5%. But the government is also proposing to ...
Commentary

Cashing In On University Patents Means Giving Up On Our Innovation Future

Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation ...
Commentary

America Can’t Tariff Its Way to a Manufacturing Boom

President Trump very recently signed an executive order exempting a range of products from his proposed tariffs, including some pharmaceuticals. One day prior, he issued an order exempting generic pharmaceuticals from Japan from tariffs. It’s encouraging news, to be sure — particularly for American patients. But policies which shield vital ...
Commentary

The illicit trade in weight-loss drugs deserves a crackdown

The market for illicit weight-loss drugs is booming in plain sight. Law enforcement officials will have no choice but to act soon. In July, telehealth firm Hims & Hers was hit with a securities lawsuit alleging that the company sold unapproved knock-off compounded versions of Wegovy in violation of its ...
Commentary

Republicans Must Stand Their Ground On Enhanced Obamacare Subsidies

A group of Republican lawmakers is trying to preserve one of the worst mistakes of former President Biden’s tenure—the enhanced subsidies for health insurance sold through Obamacare’s exchanges. The subsidies—which were first enacted on an explicitly temporary basis during the pandemic before being renewed in 2022—are set to expire at ...
Business & Economics

Penalizing Mergers And Acquisitions Won’t Accelerate Economic Growth

The U.S. is mired in a growth slowdown… The growth slowdown is not preordained; it is a policy driven outcome that can be reversed by implementing the right reforms. Toward this goal, a ruling by the U.S. Tax Court this past summer made small but significant progress. Read the op-ed ...
Commentary

Business Policy CMS Shouldn’t Expand Its Broken Competitive Bidding Model

Durable medical equipment (DME) such as CPAP machines and hospital beds helps keep many patients out of expensive nursing home care and in their own homes. Unfortunately, creating the right payment model has long eluded the Centers for Medicare and Medicaid Services (CMS). Disconcertingly, they now plan to expand a ...
Commentary

Valley residents are growing alarmed by solar-and-battery project taking over farmland. Here’s why.

We’ve been assured for quite some time that wind and solar are the energy sources of the future. If so, their development needs to be accelerated because they are not being well received by locals. Their low energy density is partly, if not largely, to blame. Fresno County residents are ...
Scroll to Top